Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.75 |
| ▸ | POLB | P06746 | 3/20 | 0.56 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 6/20 | 0.53 |
| ▸ | RAB9A | P51151 | 6/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL370724 | 0.93 | BCHE (0.86) | BCHEPOLBDDAH1GAANPC1 | |
| SCHEMBL29550341 | 0.93 | BCHE (0.86) | BCHEPOLBDDAH1GAANPC1 | |
| Magnesium SCHEMBL30119882 | 0.91 | BCHE (0.83) | BCHEPOLBDDAH1GAANPC1 | |
| SCHEMBL8201381 | 0.86 | BCHE (1.00) | BCHEPOLBDDAH1GAANPC1 | |
| SCHEMBL707879 | 0.85 | BCHE (0.73) | BCHEPOLBDDAH1GAANPC1 | |
| SCHEMBL17200183 | 0.83 | BCHE (0.65) | BCHEPOLBDDAH1GAANPC1 | |
| SCHEMBL20677816 | 0.83 | BCHE (0.87) | BCHEPOLBDDAH1GAANPC1 | |
| SCHEMBL20677807 | 0.83 | BCHE (0.87) | BCHEPOLBDDAH1GAANPC1 | |
| SCHEMBL10144030 | 0.83 | BCHE (0.75) | BCHEPOLBDDAH1GAANPC1 | |
| Hydrochloric Acid SCHEMBL710645 | 0.82 | BCHE (0.69) | BCHEPOLBDDAH1GAANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7229943-B2 | Polymerisation and oligomerisation catalysts | INNOVENE EUROPE LIMITED (GB) | 2007-06-12 | — | — | US | disclosed |
| US-20060094588-A1 | Polymerisation and oligomerisation catalysts | BARCLAYS BANK PLC (GB) | 2006-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094588-A1 | Polymerisation and oligomerisation catalysts | CCNA1, AP2M1, AP2A1 | BCHE 4523/4885POLB 1252/4885DDAH1 264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.